NASDAQ
IMCC
Last Price
US $0.14
Valuation
Financial
Performance
Financial stability - Cash flow debt coverage.
IM Cannabis Corp. cash flow to debt ratio of 28.99% indicates that the company generates enough cash to cover its debts. This level indicates strong financial health.
Financial stability - Healthy cash flow growth.
IM Cannabis Corp.'s free cash flow has increased -481.43% from $-1.23M last year to $4.70M, signaling increasing performance
Financial risk - Healthy debt to equity ratio.
IM Cannabis Corp.'s debt to equity ratio is 4.44, which means that the company's assets are unhealthy financed, signaling financial risk. READ MORE: A ratio over 0.60 means the company finances its assets with debt, signaling financial risk. If ratio is negative, the company spent its own equity and risks bankruptcy
Financial risk - Healthy debt to equity ratio development.
IM Cannabis Corp.'s debt has increased relative to shareholder equity from 3.44 last year to 4.44 today, signaling weakened financials
Financial risk - Net debt/EBITDA.
IM Cannabis Corp. has negative EBITDA, making leverage ratio unreliable
Financial risk - ICR.
IM Cannabis Corp.'s interest coverage ratio is -16.00, which means that the company struggles to meet interest obligations, signaling financial risk.
Financial stability - Profit margin growth.
IM Cannabis Corp.'s profit margin has increased (-97.29%) in the last year from -19.59% to -0.53%, signaling increasing performance
Financial risk - Short term assets vs short term liabilities.
IM Cannabis Corp.'s short-term liabilities of $34.01M exceed its short-term assets of $22.74M, signaling financial risk
Decreasing performance - ROA.
IM Cannabis Corp.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Decreasing performance - Absolute return on equity.
IM Cannabis Corp.'s return on equity of -3.03%, is lower than 15.00%, indicating bad performance
Decreasing performance - Earnings quality.
IM Cannabis Corp.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Decreasing performance - Earnings stability.
IM Cannabis Corp. had positive net income in only 0.00 out of 5 years, indicating unstable earnings
Increasing performance - Free cash flow.
IM Cannabis Corp. has positive free cash flow, indicating the company generates cash after capital expenditures
Increasing performance - FCF yield.
IM Cannabis Corp. has a free cash flow yield of 1.08K%, which is above the 2.00% threshold, indicating strong cash generation relative to market value
Decreasing performance - Healthy earnings growth.
IM Cannabis Corp.'s yearly earnings has decreased 6.93% since last year from $-10.59M to $-11.32M, signaling decreasing performance
Increasing performance - Healthy revenue growth.
IM Cannabis Corp.'s yearly revenue has increased 1.30% since last year from $54.03M to $54.73M, signaling increasing performance
Decreasing performance - ROIC.
ROIC -0.91% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
Increasing performance - 3-year revenue CAGR.
IM Cannabis Corp.'s 3-year revenue CAGR of 0.24% is positive, indicating growing revenue over the past 3 years
Increasing performance - Revenue consistency.
IM Cannabis Corp. had revenue growth in 4.00 out of 5 years, indicating consistent revenue performance
Decreasing performance - ROE consistency.
IM Cannabis Corp. had positive ROE in only 0.00 out of 5 years, indicating inconsistent returns on equity
Overvalued - DCF valuation.
IM Cannabis Corp. has insufficient data to evaluate this check.
Overvalued - Earnings yield.
IM Cannabis Corp. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Overvalued - EBITDA valuation.
IM Cannabis Corp. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model
Overvalued - EV/EBITDA.
IM Cannabis Corp. has negative or missing EBITDA, making EV/EBITDA ratio unreliable
Overvalued - PEG ratio value.
IM Cannabis Corp. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Overvalued - P/B ratio.
IM Cannabis Corp. has negative shareholder equity; price-to-book is not meaningful and the check fails
Undervalued - P/S ratio.
IM Cannabis Corp. has a price-to-sales ratio of 0.02x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
-3.03%
Return on equity
ROIC: -0.91%
Valuation History
-1062.5X
Price to Earnings
EV/EBITDA: 47.8X
Cash flow
Profit margin
0.26%
(FY vs FY)
Cash flow Y/Y
-
(FY vs FY)
Fair Value
Market $0.14
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.